These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11004813)

  • 1. [Guideline for treatment of gastroesophageal reflux disease].
    Nakamura T; Kurosawa S
    Nihon Rinsho; 2000 Sep; 58(9):1838-46. PubMed ID: 11004813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison between histamine H2-blocker and proton pump inhibitor on the effects of initial treatment in reflux esophagitis].
    Harasawa S
    Nihon Rinsho; 2000 Sep; 58(9):1847-52. PubMed ID: 11004814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management strategies for gastroesophageal reflux disease.
    Bak YT
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
    Habu Y; Oyasu K; Wakamatsu T; Sumitomo Y; Kiyota K; Inokuchi H; Kawai K
    Nihon Rinsho; 2000 Sep; 58(9):1881-5. PubMed ID: 11004820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of gastroesophageal reflux disease in adults: an individualized approach.
    Galmiche JP; Stephenson K
    Dig Dis; 2004; 22(2):148-60. PubMed ID: 15383756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroesophageal reflux disease (GERD): is there more to the story?
    Vesper BJ; Altman KW; Elseth KM; Haines GK; Pavlova SI; Tao L; Tarjan G; Radosevich JA
    ChemMedChem; 2008 Apr; 3(4):552-9. PubMed ID: 18076011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC; Wolfe MM
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Refractory GERD": acid, nonacid, or not GERD?
    Vaezi MF
    Am J Gastroenterol; 2004 Jun; 99(6):989-90. PubMed ID: 15180714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H+/K+ ATPase inhibitors in the treatment of acid-related disorders.
    Bamford M
    Prog Med Chem; 2009; 47():75-162. PubMed ID: 19328290
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of PPI-test in the diagnosis of GERD].
    Takahashi M; Nishiki R; Ichimura H; Takada H; Kuwayama H
    Nihon Rinsho; 2004 Aug; 62(8):1465-74. PubMed ID: 15344536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic GERD. Strategies to relieve symptoms and manage complications.
    Mullick T; Richter JE
    Geriatrics; 2000 Nov; 55(11):28-30, 33-4, 37-9 passim. PubMed ID: 11086471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic approaches to reflux disease, focusing on acid secretion.
    Kinoshita Y; Adachi K; Fujishiro H
    J Gastroenterol; 2003 Mar; 38 Suppl 15():13-9. PubMed ID: 12698865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapy of gastroesophageal reflux disease in secondary and tertiary care settings.
    Tytgat GN
    Yale J Biol Med; 1999; 72(2-3):219-26. PubMed ID: 10780584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pharmacologic approaches in gastroesophageal reflux disease.
    Armstrong D; Sifrim D
    Gastroenterol Clin North Am; 2010 Sep; 39(3):393-418. PubMed ID: 20951909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GERD guideline].
    Hongo M
    Nihon Rinsho; 2004 Aug; 62(8):1421-6. PubMed ID: 15344529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.